Momegen (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momegen, is a corticosteroid presented as a topical formulation for skin use. It is prescribed to reduce inflammation and immune responses in various dermatologic conditions.

GNH USA supplies Momegen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Momegen, a topical corticosteroid, is employed to manage inflammatory skin disorders. - Psoriasis: reduces scaling and erythema, improving plaque appearance. - Atopic dermatitis: alleviates itching and inflammation, helping restore skin barrier function. - Allergic contact dermatitis: diminishes redness and swelling caused by allergen exposure. - Seborrheic dermatitis: controls flaking and irritation on scalp and face.

Topical application of Momegen may be associated with a range of adverse reactions.

Common Side Effects: - Burning or stinging at the application site. - Pruritus or mild itching. - Dryness or peeling of the skin. - Erythema or mild redness. - Folliculitis or small pustules.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible small blood vessels). - Secondary bacterial, fungal or viral skin infections. - Hypersensitivity reactions such as contact dermatitis. - Systemic effects like adrenal suppression when used over large areas.

Before using Momegen, consider the following safety measures. - Application area: limit to affected skin and avoid large surface areas. - Duration of therapy: use for the shortest period necessary to control symptoms. - Concomitant skin infection: treat any bacterial, fungal or viral infection before applying. - Age restrictions: avoid use on infants unless specifically prescribed. - Occlusive dressings: do not cover treated skin with airtight dressings unless directed. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Momegen may interact with other agents that affect skin integrity or systemic corticosteroid exposure.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use can increase risk of systemic effects. - Potent topical antibiotics or antifungals: may enhance local irritation.

Moderate Interactions (Monitor Closely): - Skin barrier‑disrupting agents (e.g., keratolytics): may increase absorption. - Immunosuppressive drugs: monitor for heightened infection risk. - Phototherapy: may increase photosensitivity, requiring sun protection.